The WAIVS research team is creating an AO platform consisting of two AO Scanning Laser Ophthalmoscope imaging systems; one for use in human subject research with over-arching goals of understanding retinal pathology on a cellular scale and exploring novel ways to monitor therapeutic response to innovative retinal therapeutics, including gene and stem cell-based therapies; and a system dedicated for animal research and optical imaging innovation in the visual system.
This AO platform provides an integrated environment where human subject imaging will motivate R&D leading to innovations that are developed and optimized on the research system and then rapidly translated back to human subject imaging.
